Filing Details
- Accession Number:
- 0001562180-24-004758
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-06 17:42:19
- Reporting Period:
- 2024-06-04
- Accepted Time:
- 2024-06-06 17:42:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1645113 | Novocure Ltd | NVCR | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236183 | Gabriel Leung | C/O Novocure Inc. 1550 Liberty Ridge Drive, Suite 115 Wayne PA 19087 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2024-06-04 | 964 | $23.89 | 78,175 | No | 4 | S | Direct | |
| Restricted Stock Units | Acquisiton | 2024-06-05 | 4,053 | $0.00 | 83,192 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (Right to Buy) | Acquisiton | 2024-06-05 | 6,229 | $0.00 | 6,229 | $23.13 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 6,229 | 2034-06-04 | No | 4 | A | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $23.75 USD to $24.00 USD; the price reported above reflects the weighted average sale price.
- These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders.
- Options to buy 6,229 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders.
Billionaire Hedge Funds
